Implementation of the regional program of cervical cancer screening by liquid-based cytology in the Rostov region
https://doi.org/10.17709/2409-2231-2019-6-4-5
Abstract
Purpose of the study. To evaluate the effectiveness of the regional cervical cancer screening program by (LB) liquid‑based cytology.
Materials and methods. The geography of screening includes 54 medical units of the Rostov region, where patients are taken swabs from the cervix. HPV positive patients with abnormal PAP smears are invited to the Regional cervical pathology center (RCPC) for diagnosis and treatment. LB cytology, the HPV test RealTime PCR, colposcopy with video recording, biopsy of the cervix by the method of loop excision or electroradiographic conization.
Results. From 2014 to 2017, 188 641 cytology tests were performed. Cervical cancer was revealed in 189 women — (0.1%), H‑SIL and ASCH in 566 (0.3%), 377 ASCUS (0.2%), L‑SIL in 23014 (12.2%), absence of intracellular lesions or malignancy (NILM) in 164495 (87.2%). 2162 HPV — positive women aged 18 to 69 years were invited to the RCPC gynecologist for examination. Treatment by conization (622) and excision (830) of the cervix was performed in 1452 patients, H‑SIL and CIS were revealed in 1162 women (78%).
Conclusion. tests such as LB cytology and HPV testing, their optimal multiplicity and sequence allow timely detection and treatment of precancerous cervical epithelium lesions.
About the Authors
Т. A. Dimitriadi
Regional Advisory and Diagnostic Centre
Russian Federation
Russian Federation
Tatiana A. Dimitriadi - MD, PhD, head of the Regional Center of Cervical Pathology Regional Advisory and Diagnostic Centre.
127 Pushkinskaya str., Rostov-on-don 344011.
D. V. Burtsev
Regional Advisory and Diagnostic Centre
Russian Federation
Russian Federation
Dmitriy V. Burtsev - MD, PhD, DSc, chief physician Regional Advisory and Diagnostic Centre, associate professor of the Department of Oncology Rostov Institute of Oncology.
127 Pushkinskaya str., Rostov-on-don 344011.
E. A. Dzhenkova
Rostov Institute of Oncology
Russian Federation
Russian Federation
Elena A. Dzhenkova - PhD, DSc (Biology), associate professor, scientific secretary Rostov Institute of Oncology.
63 14 liniya, Rostov-on-Don 344037.
References
1. WHO guidelines for screening and treatment of precancerous lesions for cervical cancer prevention. Geneva: World Health Organization;2013. Доступно по: http://mom.gov.az/resources/content_files/ebook/treatment%20of%20precancerous%20_eng.pdf
2. Аксель Е. М. Заболеваемость и смертность от злокачественных новообразований органов женской репродуктивной системы в России. Онкогинекология. 2015; 1:6-15.
3. US Preventive Services Task Force Recommendation Statement. Screening for Cervical Cancer. JAMA. 2018;320(7):674-686. DOI:10.1001/jama.2018.10897
4. Judith A. Anaman-Torgbor, Julie King, Ignacio Correa-Velez Barriers and facilitators of cervical cancer screening practices among African immigrant women living in Brisbane, Australia. European Journal of Oncology Nursing, 2017; 31:22-29. DOI: 10.1016/j.ejon.2017.09.005
5. US Preventive Services Task Force Recommendation Statement. Screening for Cervical Cancer. JAMA. 2018;320(7):674-676. DOI:10.1001/jama.2018.10897
6. Димитриади Т. А., Кит О. И., Бурцев Д. В., Скрининг рака шейки матки. Мировой опыт. Ситуация в России. Известия высших учебных заведений. Северо-Кавказский регион. Серия: Естественные науки. 2017; 4-2(196-2):26-32.
Review
For citations:
Dimitriadi Т.A., Burtsev D.V., Dzhenkova E.A. Implementation of the regional program of cervical cancer screening by liquid-based cytology in the Rostov region. Research and Practical Medicine Journal. 2019;6(4):54-59. (In Russ.) https://doi.org/10.17709/2409-2231-2019-6-4-5
Views:
1062
Email this article 